Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: "Commission Directive 2000/32/EC, L1362000, Annex 4D", dated May 19, 2000
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- - Name of the test material (as cited in the study report: FAT 40842/A TE
- Substance type: coloring dye
- Physical state: solid, dark bluish green powder
- Analytical purity: 96%
- Lot/batch No.: Blau DRI 2098 Op 1/07
- Expiration date of the lot/batch: June 30, 2014
- Storage condition of test material: at room temperature at about 20 ºC
Method
- Target gene:
- see Table 1 "any other information on materials and methods incl. tables"
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Test concentrations with justification for top dose:
- Pre-Experiment/Experiment I and Ia: 3; 10; 33; 100; 333; 1000; 2500; and 5000 Lg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle:The solvent was chosen because of its solubility properties and its relative non-toxicity to the bacteria
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: NaN3 = sodium azide 4-NOPD = 4-Nitro-o-phenylene-diamine MMS = methyl methane sulfonate 2-AA = 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation); preincubation;
For each strain and dose level, including the controls three plates were used. The following materials were mixed in a test tube and poured onto the selective agar plates (first experiment):
- 100 μl Test solution at each dose level, solvent (negative control) or reference mutagen solution (positive control),
- 500 μl S9 mix (for test with metabolic activation) or S9 mix substitution buffer (for test without metabolic activation),
- 100 μl Bacteria suspension (cf. test system, pre-culture of the strains),
- 2000μl Overlay agar
After solidification the plates were incubated upside down for at least 48 hours at 37° C in the dark.
Rat S9 Mix
Before the experiment an appropriate quantity of S9 supernatant was thawed and mixed with S9 co-factor solution. The amount of S9 supernatant was 10% v/v in the S9 mix. Cofactors are added to the S9 mix to reach the following concentrations in the S9 mix:
8 mM MgCl2
33 mM KCl
5 mM glucose-6-phosphate
5 mM NADP
in 100 mM sodium-ortho-phosphate-buffer, pH 7.4.
During the experiment the S9 mix was stored in an ice bath. The S9 mix preparation was performed according to Ames et al.(2).
During the experiment the S9 mix was stored in an ice bath. The S9 mix preparation was performed according to Ames et al.(2) and Prival and Mitchell (1).
1. Prival. M.J. and V.D. Mitchell (1982)
Analysis of a method for testing azo dyes for mutagenic activity in Salmonella
typhimurium in the presence of flavin mononucleotide and hamster liver S9
Mutation Res. 97, 103-116
2. Ames, B.N., W.E. Durston, E. Yamasaki, and F.D. Lee (1973)
Carcinogens are mutagens: a simple test system combining liver homogenates for
activation and bacteria for detection
Proc. Natl. Acad. Sci. (USA) 70, 2281-2285 - Evaluation criteria:
- A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA 98, TA 100, and WP2 uvrA) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control is observed (3).
A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration (2).
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant. - Statistics:
- No statistical evaluation of the data is required
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no significant effects by test item
- Effects of osmolality: no significant effects by test item
- Evaporation from medium: no
- Water solubility: low, suspended homogeniously in DMSO
- Precipitation: Precipitation of the test item was observed either in the overlay agar in the test tubes at 5000 Lg/plate and on the incubated agar plates from 333 Lg/plate up to 5000 Lg/plates.
- Other confounding effects: no
COMPARISON WITH HISTORICAL CONTROL DATA:
attached to the report
ADDITIONAL INFORMATION ON CYTOTOXICITY: no - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'. Remarks: reverse mutation assay
Any other information on results incl. tables
- Pre-Experiment/Experiment I
Metabolic Activation |
Test Group |
Dose Level (µg/plate) |
|
Revertant Colony Counts (Mean ±SD) |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
WP2 uvrA |
|
|
|
|
|
|
|
|
|
Without Activation |
DMSO |
|
|
23 ± 10 |
16 ± 5 |
33 ± 10 |
137 ± 17 |
49 ± 4 |
Untreated |
|
|
25 ± 5 |
13 ± 4 |
35 ± 8 |
148 ± 10 |
57 ± 15 |
|
FAT 40842/ATE |
3 µg |
|
18 ± 5 |
14 ± 3 |
35 ± 13 |
127 ± 7 |
47 ± 6 |
|
|
10 µg |
|
16 ± 4 |
16 ± 1 |
35 ± 11 |
127 ± 2 |
46 ± 3 |
|
|
33 µg |
|
21 ± 7 |
18 ± 10 |
37 ± 8 |
152 ± 19 |
47 ± 3 |
|
|
100 µg |
|
23 ± 8 |
17 ± 2 |
45 ± 3 |
143 ± 12 |
52 ± 10 |
|
|
333 µg |
|
23 ± 3P |
16 ± 2P |
39 ± 7P |
146 ± 6P |
51 ± 17P |
|
|
1000 µg |
|
20 ± 7P |
19 ± 4P |
48 ± 2P |
154 ± 10P |
44 ± 4P |
|
|
2500 µg |
|
16 ± 1P |
20 ± 8P |
61 ± 9P |
146 ± 24P |
51 ± 14P |
|
|
5000 µg |
|
18 ± 3P |
17 ± 2P |
52 ± 13P |
158 ± 4P |
45 ± 4P |
|
NaN3 |
10 µg |
|
2313 ± 42 |
|
|
2080 ± 71 |
|
|
4-NOPD |
10 µg |
|
|
|
405 ± 17 |
|
|
|
4-NOPD |
50 µg |
|
|
110 ± 10 |
|
|
|
|
MMS |
3.0 µL |
|
|
|
|
|
1226 ± 92 |
|
|
|
|
|
|
|
|
|
|
With Activation |
DMSO |
|
|
23 ± 4 |
23 ± 10 |
48 ± 13 |
142 ± 13 |
67 ± 3 |
Untreated |
|
|
22 ± 5 |
15 ± 2 |
40 ± 2 |
149 ± 19 |
71 ± 10 |
|
FAT 40842/ATE |
3 µg |
|
33 ± 10 |
31 ± 6 |
166 ± 21 |
178 ± 5 |
70 ± 6 |
|
|
10 µg |
|
25 ± 8 |
37 ± 3 |
173 ± 22 |
164 ± 25 |
55 ± 3 |
|
|
33 µg |
|
22 ± 5 |
29 ± 6 |
170 ± 22 |
163 ± 15 |
69 ± 9 |
|
|
100 µg |
|
19 ± 8 |
24 ± 4 |
160 ± 26 |
165 ± 4 |
47 ± 6 |
|
|
333 µg |
|
22 ± 2P |
22 ± 5P |
161 ± 10P |
166 ± 15P |
48 ± 2P |
|
|
1000 µg |
|
22 ± 4P |
19 ± 2P |
132 ± 10P |
164 ± 8P |
58 ± 5P |
|
|
2500 µg |
|
13 ± 2P |
21 ± 1P |
155 ± 9P |
170 ± 11P |
65 ± 2P |
|
|
5000 µg |
|
17 ± 4P |
25 ± 7P |
156 ± 11P |
180 ± 16P |
65 ± 6P |
|
2-AA |
2.5 µg |
|
235 ± 15 |
226 ± 12 |
1558 ± 66 |
1628 ± 515 |
|
|
2-AA |
10.0 µg |
|
|
|
|
|
379 ± 133 |
Key to Positive Controls |
Key to Plate Postfix Codes |
||
|
|
||
NaN3 2-AA 4-NOPD MMS |
sodium azide 2-aminoanthracene 4-nitro-o-phenylene-diamine methyl methane sulfonate |
P |
Precipitate |
- Experiment I a
Metabolic Activation |
Test Group |
Dose Level (µg/plate) |
|
Revertant Colony Counts (Mean ±SD) |
|
|
|
|
|
|
|
|
|
TA 98 |
|
|
|
|
|
Without Activation |
DMSO |
|
|
27 ± 7 |
Untreated |
|
|
40 ± 4 |
|
FAT 40842/ATE |
3 µg |
|
35 ± 2 |
|
|
10 µg |
|
36 ± 5 |
|
|
33 µg |
|
39 ± 2 |
|
|
100 µg |
|
46 ± 6 |
|
|
333 µg |
|
59 ± 7P |
|
|
1000 µg |
|
61 ± 6P |
|
|
2500 µg |
|
63 ± 2P |
|
|
5000 µg |
|
66 ± 5P M |
|
4-NOPD |
10 µg |
|
482 ± 38 |
|
|
|
|
|
|
With Activation |
DMSO |
|
|
38 ± 3 |
Untreated |
|
|
38 ± 4 |
|
FAT 40842/ATE |
3 µg |
|
131 ± 10 |
|
|
10 µg |
|
133 ± 11 |
|
|
33 µg |
|
143 ± 7 |
|
|
100 µg |
|
157 ± 19 |
|
|
333 µg |
|
165 ± 14P |
|
|
1000 µg |
|
172 ± 23P |
|
|
2500 µg |
|
161 ± 5P |
|
|
5000 µg |
|
176 ± 7P M |
|
2-AA |
2.5 µg |
|
1683 ± 52 |
|
|
|
|
|
|
Key to Positive Controls |
Key to Plate Postfix Codes |
||
|
|
||
4-NOPD 2-AA |
4-nitro-o-phenylene-diamine 2-aminoanthracene |
P M |
Precipitate Manual count |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
positive with metabolic activation
positive without metabolic activation
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did induce gene mutations by frameshifts in the genome of strain TA 98 with and without of metabolic activation.
Therefore, FAT 40842/A TE is considered to be mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay. - Executive summary:
The present study (Sokolowski 2009) was performed to investigate the potential of FAT 40842/A TE to induce gene mutations according to the plate incorporation assay with rat liver S9 (experiment I) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and the Escherichia coli strain WP2 uvrA.
The assay was performed with and without liver microsomal activation. A confirmatory experiment was performed with and without rat S9 mix with strain TA 98 (reported as experiment Ia). Each concentration, including the controls, was tested in triplicate. The test item was tested at the following concentrations:
Pre-Experiment/Experiment I and Ia: 3; 10; 33; 100; 333; 1000; 2500; and 5000 Lg/plate
The plates incubated with the test item showed normal background growth up to 5000 Lg/plate with and without metabolic activation. No toxic effects, evident as a reduction in the number of revertants, were observed with and without metabolic activation.
A moderate but dose dependent increase in revertant colony numbers was observed following treatment with FAT 40842/A TE in strain TA 98 with and without rat S9 mix.
Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies.
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did induce gene mutations by frameshifts in the genome of strain TA 98 with and without of metabolic activation.
Therefore, FAT 40842/A TE is considered to be mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.